Metabolic-Fit / 100
KERNX Health review
Credit where it is due: KERNX prints both numbers side by side, which most sellers do not. The card reads "From $129/mo · $249/mo after founding period" for semaglutide and "From $199/mo · $299/mo" for tirzepatide, so the introductory rate and the one you will actually settle on are visible in the same glance. What that honesty reveals is a steep climb — 93% on semaglutide and 50% on tirzepatide — and there is a second cost that sits outside both figures entirely: "consultation fees range from $25 to $60", charged separately. Budget $249 plus a consult fee, not $129, and the decision looks different.
then $249/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
KERNX Health at a glance
- Semaglutide
- $249/mo once the founding period ends
- Tirzepatide
- $299/mo once the founding period ends
- Coverage
- Not stated on the site
- Brand-name
- Compounded only
How we scored KERNX Health
Every factor comes from KERNX Health's own published pricing, disclosures and oversight, and the six combine into the 35/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- kernxhealth.com
Read from KERNX Health's own product cards in August 2026. It publishes both prices together: semaglutide is $129 a month during a founding period and $249 after it, tirzepatide $199 then $299 — increases of 93% and 50%. Consultation fees of $25 to $60 are charged separately and are not included in either figure, and the length of the founding period is not stated.
What to expect when you sign up
We walked KERNX Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves kernxhealth.com for shop.kernxhealth.com, a separate host
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
- Intake is hosted on shop.kernxhealth.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $129 → $249 | After founding period"From $129/mo · $249/mo after founding period". A consultation fee of $25 to $60 is charged separately and is not in either figure. |
| Compounded tirzepatide | $199 → $299 | After founding period"From $199/mo · $299/mo after founding period", plus the same separate consultation fee. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what KERNX Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Publishes the post-founding price directly beside the founding one — visible in a single glance
- States plainly that consultation fees exist and gives their range rather than hiding them
- Cash-pay platform with no insurance ambiguity
The caveats
- The medication price rises steeply once the founding period ends — $129 to $249 for semaglutide, a 93% increase, and $199 to $299 for tirzepatide
- Consultation fees of $25 to $60 sit on top of those figures and are not included in either
- The founding period is described as limited but its length is never stated
- Prices are "from", so your dose may move them
- It does not say which states it serves
KERNX Health for mothers: our verdict
Credit where it is due: KERNX prints both numbers side by side, which most sellers do not. The card reads "From $129/mo · $249/mo after founding period" for semaglutide and "From $199/mo · $299/mo" for tirzepatide, so the introductory rate and the one you will actually settle on are visible in the same glance. What that honesty reveals is a steep climb — 93% on semaglutide and 50% on tirzepatide — and there is a second cost that sits outside both figures entirely: "consultation fees range from $25 to $60", charged separately. Budget $249 plus a consult fee, not $129, and the decision looks different. The advertised entry is $129, but the standing rate settles near $249/month — so read the headline as a starting offer, not the monthly cost.
We weigh KERNX Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What KERNX Health costs, in full
- Compounded semaglutide — After founding period: $129 to start, then $249/mo
- Compounded tirzepatide — After founding period: $199 to start, then $299/mo
For context, the typical ongoing price across our roster is around $179/month, so KERNX Health sits at the premium end.
KERNX Health says the price covers the medication, and that the provider visit is billed separately. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications KERNX Health prescribes
KERNX Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where KERNX Health fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything KERNX Health states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
KERNX Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who has done the arithmetic on the post-founding price plus a consultation fee and still finds it works.
Alternatives to KERNX Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing KERNX Health
Head-to-head & alternatives
KERNX Health, answered
- How much does KERNX Health cost?
- At last review, KERNX Health's lowest ongoing compounded rate was about $249 a month — $249/mo once the founding period ends for semaglutide, $299/mo once the founding period ends for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is KERNX Health safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. KERNX Health is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does KERNX Health offer both semaglutide and tirzepatide?
- Yes — KERNX Health offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does KERNX Health rank for mothers?
- KERNX Health scores 35/100 on our Metabolic-Fit Score and sits at #239. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect KERNX Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.